tiprankstipranks

Andrew Schiff Insider Profile

11 Followers
Andrew Schiff, Director at Monte Rosa Therapeutics, holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE), holds 460.00K shares in Aclaris Therapeutics (Ticker: ACRS), holds 2.10M shares in Zeltiq Aesthetics (Ticker: ZLTQ). Most recently, Andrew Schiff ― shares of Monte Rosa Therapeutics on ― for an estimated value of ―.
tipranks
Andrew Schiff

Andrew Schiff
Monte Rosa Therapeutics (GLUE)
Director

Ranked #72,034 out of 109,030 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-10.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
A breakdown of Andrew Schiff's holdings

Insider Roles

Aclaris Therapeutics
(ACRS)
Director
Monte Rosa Therapeutics
(GLUE)
Director
Roles that Andrew Schiff holds in companies

Most Profitable Insider Trade

Stock:
Agile Therapeutics
(AGRX)
Rating:Informative Buy
Date:May 28, 2014 - May 28, 2015
Return:+67.40%
The most profitable trade made by Andrew Schiff

Andrew Schiff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Monte Rosa Therapeutics
Director
Aclaris Therapeutics
Jun 08, 2026
Director
Uninformative Buy
50.49K
$2.45M
ZLTQ
Zeltiq Aesthetics
May 01, 2017
Uninformative Sell
$118.87M
AGRX
Agile Therapeutics
May 28, 2014
Informative Buy
8.00M
$3.28M
List of latest transactions for each holding click on a transaction to see Andrew Schiff's performance on stock

Andrew Schiff insider profile FAQ

What is the percentage of profitable transactions made by Andrew Schiff?
The percentage of profitable transactions made by Andrew Schiff is 25%.
    What is the average return per transaction made by Andrew Schiff?
    The average return per transaction made by Andrew Schiff is -10.90%.
      What stocks does Andrew Schiff hold?
      Andrew Schiff holds: GLUE, ACRS, ZLTQ, AGRX stocks.
        What was Andrew Schiff’s latest transaction?
        Andrew Schiff latest transaction was an Uninformative Buy of ―.
          What was Andrew Schiff's most profitable transaction?
          Andrew Schiff’s most profitable transaction was an Informative Buy of AGRX stock on May 28, 2014. The return on the trade was 67.40%.
            What is Andrew Schiff's role in Monte Rosa Therapeutics?
            Andrew Schiff's role in Monte Rosa Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.